00874 白雲山
公司資料 - 財務狀況表
廣州白雲山醫藥集團股份有限公司 股票編號: 00874
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED 集團網址: http://www.gybys.com.cn
非流動資產
2024/12 - 末期
人民幣(K¥)
與去年末期
比較
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
投資物業145,072-14.551%169,775206,705213,976213,002
物業、廠房、設備及其他7,376,2068.714%6,784,9695,817,5104,911,6834,188,765
租賃土地1,656,133-10.574%1,851,9671,550,0861,585,3711,581,658
無形資產2,564,889-1.077%2,592,8222,614,6452,596,3322,596,841
聯營公司及共同控制公司權益1,507,259-16.525%1,805,6421,584,0631,562,8791,865,866
其他非流動資產10,671,82413.554%9,397,9895,827,9782,436,9751,917,312
23,921,3835.832%22,603,16417,600,98713,307,21512,363,445
存貨12,811,90211.339%11,507,10010,671,57310,437,7349,764,531
 
流動資產
現金及銀行結存18,273,150-14.246%21,308,84422,499,55322,376,92819,470,276
其他流動資產26,677,17615.148%23,167,77023,893,18619,995,91318,161,810
持作出售資產0--0000
57,762,2283.177%55,983,71457,064,31252,810,57447,396,618
 
流動負債
其他流動負債38,915,6897.397%36,235,29137,395,11632,253,85129,243,232
持作出售資產相關負債0--0000
38,915,6897.397%36,235,29137,395,11632,253,85129,243,232
流動資產淨值18,846,539-4.567%19,748,42319,669,19620,556,72318,153,386
資產總額減流動負債42,767,9220.983%42,351,58737,270,18333,863,93930,516,831
 
非流動負債
4,998,286-11.905%5,673,7633,632,3252,537,2702,311,564
 
資本及儲備
   股本1,625,7910.000%1,625,7911,625,7911,625,7911,625,791
   儲備34,278,7372.959%33,293,49030,439,33427,436,39424,519,052
   其他0--0000
股東資金35,904,5282.821%34,919,28132,065,12529,062,18426,144,843
非控股權益1,865,1086.060%1,758,5431,572,7332,264,4842,060,424
其他0--0000
37,769,6362.977%36,677,82433,637,85831,326,66928,205,267
 
承擔及或然負債
承擔5,435,85031.750%4,125,8923,176,2092,732,1943,686,948
或然負債0--0000
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.